Article: Peplin Posts Results for the 2009 Financial Year Ended June 30


Wireless News
09-03-2009
Peplin Posts Results for the 2009 Financial Year Ended June 30
Type: News

Peplin, Inc. has announced financial results for the year ended 30 June 2009, reporting a US$17.7 million cash balance.

In a release on August 31, the Company noted that it will use these funds to complete Phase 3 clinical trials for its lead product, PEP005 (ingenol mebutate) Gel for actinic (solar) keratosis (AK). The company is confident it will have access to sufficient working capital to fund operations through its planned New Drug Application (NDA) filing with the Food and Drug Administration (FDA) in mid-2010.
Chairman and CEO Tom Wiggans described the year as one of tremendous ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!